project id: TCGA-PRAD; case submitter id: TCGA-XK-AAIR; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.87; rna integrity number: 9.2; age at index: 75; days to birth: -27703; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 27703; ajcc clinical m: M0; ajcc clinical t: T1c; ajcc pathologic n: N0; ajcc pathologic t: T2c; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 972.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 897; days to sample procurement: 0; initial weight: 10.0; sample id: 75c3c1c1-0348-49c5-90a8-0f9c5aabe49f; sample submitter id: TCGA-XK-AAIR-01A; portion id: 096ab62b-8b25-462c-9b2d-2e636a272449; portion submitter id: TCGA-XK-AAIR-01A-11; slide id: fde3ae0a-828c-494f-957d-3fcad7d8ce4a; slide submitter id: TCGA-XK-AAIR-01Z-00-DX1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 15.0; percent stromal cells: 25.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0; section location: TOP;